<DOC>
	<DOC>NCT00829738</DOC>
	<brief_summary>The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.</brief_summary>
	<brief_title>Efficacy of Pantoprazole 20/40 mg Once Daily (od) in Patients Older Than 12 Years Who Have Gastrointestinal Symptoms of Reflux Disease</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<criteria>Main inclusion criteria: Outpatients with gastroesophageal reflux disease (GERD) Main exclusion criteria: Criteria as defined in the Summary of Product Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>PPI therapy</keyword>
	<keyword>pantoprazole</keyword>
	<keyword>GERD (Erosive Gastroesophageal Reflux Disease)</keyword>
</DOC>